Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity

Interplay Between Heme Oxygenase-1 and miR-378 Affects Non-Small Cell Lung Carcinoma Growth, Vascularization, and Metastasis

(2013) Klaudia Skrzypek et al.   ANTIOXIDANTS & REDOX SIGNALING

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells

(2013) Daniele Tibullo et al.   CURRENT PHARMACEUTICAL DESIGN

Heme Oxygenase-1 in Lung Disease

(2012) Chintan M. Raval et al.   CURRENT DRUG TARGETS

Expression and function of heme oxygenase-1 in human gastric cancer

(2012) Yujing Yin et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Carbon monoxide: An unusual drug

(2012) Francesca Gullotta et al.   IUBMB LIFE

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

(2012) Alice Dewdney et al.   JOURNAL OF CLINICAL ONCOLOGY

High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients

(2012) Jong-Rung Tsai et al.   CELLULAR ONCOLOGY

Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer

(2011) M. Ferrando et al.   ANGIOGENESIS

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors

(2011) Jun Fang et al.   CANCER SCIENCE

Protective role of heme oxygenase-1 against inflammation in atherosclerosis

(2011) William Durante   Frontiers in Bioscience-Landmark

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer

(2011) Yogesh K. Vashist et al.   JOURNAL OF SURGICAL ONCOLOGY

Heme oxygenase-1 activation inhibits XMRV pathogenesis and carcinogenesis in prostate cancer cells

(2011) Subhash Dhawan   Retrovirology

A Central Role of Heme Oxygenase-1 in Cardiovascular Protection

(2010) Meng-Ling Wu et al.   ANTIOXIDANTS & REDOX SIGNALING

Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer

(2010) D. G. Jayne et al.   BRITISH JOURNAL OF SURGERY

The therapeutic potential of carbon monoxide

(2010) Roberto Motterlini et al.   NATURE REVIEWS DRUG DISCOVERY

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo

(2009) Philipp Nuhn et al.   Molecular Cancer

CO and bilirubin inhibit doxorubicin-induced cardiac cell death

(2008) Do-Sung Kim et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy

(2008) Lei Shi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-κB activation and cell proliferation in human breast cancer MCF-7 cells

(2008) Ruben Ruiz-Ramos et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Pharmacological and Clinical Aspects of Heme Oxygenase

(2008) N. G. Abraham et al.   PHARMACOLOGICAL REVIEWS